Drugs / Shugan Jieyu Capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05772104 | Apr 2023 → Feb 2025 overdue | generalized anxiety disorder | Sichuan Jishengtang Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shugan Jieyu Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05772104 ↗ |
| Route | Oral | “Oral, 4 Capsules, BID” NCT05772104 ↗ |